
|Articles|January 15, 2005
ACES/SEE meeting provides cutting-edge information
Fort Lauderdale, FL—This year's meeting of the American College of Eye Surgeons (ACES) may be going to the dogs, but it is not because the association is joining for the second year with the Society for Excellence in Eyecare (SEE).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
3
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
4
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
5















































.png)


